Mucopolysaccharidosis III
Rare Disease·MeSH: Mucopolysaccharidosis III
Prevalence
5.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Mucopolysaccharidosis III?
BioSniper tracks 1 drug in development for Mucopolysaccharidosis III across 1 company.
How many clinical trials target Mucopolysaccharidosis III?
There are 2 clinical trials targeting Mucopolysaccharidosis III tracked by BioSniper.
What is the prevalence of Mucopolysaccharidosis III?
The estimated prevalence of Mucopolysaccharidosis III is approximately 5.0 per 100,000 population.
Deep-dive into Mucopolysaccharidosis III
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis